17 Dec 2020

Happy Holidays from Quantify!

2020-12-17T08:33:06+01:00December 17, 2020|Other|

2020 has been a year of challenge and change for Quantify, the life science industry and society at large. We are heartened by the way people have come together to support one another, and this year we are especially proud […]

18 Sep 2020

QUANTIFY becomes an ENCePP partner

2020-09-21T09:28:54+02:00September 18, 2020|All, Other|

Coordinated by EMA, the European Network of Centers for Pharmacoepidemiology & Pharmacovigilance (ENCePP) is an initiative that brings together expertise and resources in pharmacoepidemiology and pharmacovigilance across Europe with the aim to facilitate the conduct of high quality, multi-center, independent […]

25 Aug 2020

Paper on Economic consequences of migraine in Sweden, and the cost-effectiveness of Botox for chronic migraine in Sweden and Norway’, co-authored by Quantify, has been published in JHP

2020-08-25T09:04:12+02:00August 25, 2020|Other|

The paper ‘Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway’ co-authored by Quantify’s Fredrik Borgström, Amanda Hansson-Hedblom and Isabelle Axelsson, has been published in the Journal of […]

14 Apr 2020

Quantify announces new CEO

2020-04-14T13:23:26+02:00April 14, 2020|All, Other|

Quantify is pleased to announce the appointment of Kirk Geale as the new CEO of Quantify Research, replacing Åsa By after 7 highly successful years. Quantify is grateful to Åsa for the visionary leadership and energy she brought to the […]

20 Dec 2019

Quantify supports MSF

2020-04-07T08:28:19+02:00December 20, 2019|All, Other|

The winter holidays are a time of giving. Healthcare after a natural disaster for example. Therefore, Quantify has made a donation to Médecins Sans Frontières (MSF), supporting their lifesaving work. Our Christmas gift is enough to […]